GovChime
AWARDDEFINITIVE CONTRACTOther than small business

Definitive contract 75N93023C00014INNOVATION PATHWAYS LLC

Overview

Award facts

Net obligations
$3.61M
$3,608,865of $3.61M potential value
Outlays (paid to date)
$2.81M
$2.81M paid of $3.61M obligated$2,807,269
Period of performance
Jul 1, 2023 to Jun 30, 2027
Ends in 7 months
Modifications
8
Latest action Jul 28, 2026
Contract type
Definitive contract
PIID 75N93023C00014

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

THE PHARMACOLOGICAL DEVELOPMENT OF IPW-5371 FUMARATE AS A RADIATION MEDICAL COUNTERMEASURE FOR THE TREATMENT OF DELAYED RADIATION LUNG INJURY UNDER THE FDA ANIMAL RULE

Dates and value

Award date
Signed on Jun 29, 2023
Current value
$3,608,865Base and exercised options
Potential value (if all options are exercised)
$3,608,865

Obligations by fiscal year of action

  • FY2026: $109,177
  • FY2025: $499,908
  • FY2024: $1,499,864
  • FY2023: $1,499,916

Total across 4 fiscal years: $3,608,865

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jul 28, 2026. View on USAspending

Recipient

NameINNOVATION PATHWAYS LLC
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt

Business types and certifications

For-profit organizationLimited liability companyCorporation (not tax-exempt)

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Awarded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded from
Nih office of the director (0846)Program activities075-0846Federal accounts (agency financial reports)

Place of performance

Place of performance
Palo Alto, California

Classification and competition

Classification

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Negotiated proposal/quoteNP
Set-aside
No set-aside used
Contract pricing
Cost plus fixed feeU
Offers received
16

Solicitation and notices

Solicitation ID
75N93021R00019
Solicitation date
Dec 17, 2021
Notices

Contract details

Subcontracting plan
Individual subcontract planF
Major program
The pharmacological development of IPW-5371 fumarate as a radiation medical countermeasure for the t
Cost Accounting Standards clause
Not applicable exempt from CASX
Certified cost or pricing data
No
Service Contract Act labor standards
No
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
No - service where PBA is not used.N

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Jun 29, 2023Base obligation at award: $1,499,916
Latest action
Jul 28, 2026 — Funding onlyModification P00008; obligation change +$109,177; funding only: changes obligations, not scope
Latest substantive action
Jul 14, 2025 — Change orderModification P00005; obligation change +$499,908
Latest funding action
Jul 28, 2026 — Funding onlyModification P00008; obligation change +$109,177; funding only: changes obligations, not scope
Actions by type
  • Base award1
  • Other administrative action5
  • Funding only1
  • Change order1
  • Option exercised1
9 actions recorded, Jun 29, 2023 to Jul 28, 2026; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Simplified procedures for commercial items
No

Pricing and financing

Paid by purchase card
No
Latest action: change in base and exercised options
$109,177
Latest action: change in base and all options
$109,177

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Definitive contractD
Awarding agency code
7500
Awarding sub-tier code
7529
Contracting office code
75N930
Transactions recorded under this award key
9

Funding

Funding agency code
7500
Funding sub-tier code
7529
Funding office code
75N930
Treasury accounts
  • 075-2023/2023-0846-000
  • 075-2024/2024-0846-000
  • 075-2025/2025-0846-000
  • 075-2026/2026-0846-000
Object classes
  • 25.5: Research and development contracts
Disaster or emergency funding (DEFC)
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression